Skin aging is a primary dermatological concern, classified into intrinsic aging (natural, time-related) and extrinsic aging (due to environmental factors)—aging results from accumulated cellular and tissue damage.
According to the free radical theory, reactive oxygen species (ROS) from cellular metabolism play a key role in chronological aging and photoaging. Other contributors to intrinsic aging include telomere shortening, mitochondrial and genetic mutations, and hormonal decline.
Extrinsic aging, mainly caused by UV exposure, accounts for about 80% of facial skin aging. Other external factors include smoking, pollution, infrared radiation, and poor nutrition.

Visible signs of aging—dryness, pigmentation changes, and reduced elasticity—are linked to collagen degradation. Collagen, especially Types I and III, forms the skin’s structural foundation, comprising about 30% of total body protein.
Our clinically studied bioactive marine collagen peptides help rebuild skin structure from within. Their skin benefits are backed by three clinical studies—each double-blind, randomized, placebo-controlled, and conducted under French regulatory standards with Ethics Committee (CPP) approval. Biomechanical skin measurements were overseen by certified dermatologists, ensuring scientific rigor and reliability. Clinical trials confirm that daily intake of marine collagen peptides, from as little as 2.5 g/day, significantly improves key signs of skin aging—including hydration, elasticity, firmness, wrinkle reduction, and overall skin tone, as well as the strength of hair and nails. Another study demonstrated that a higher daily oral dose of 10 g of the clinically tested marine collagen peptides enhances joint health benefits.


References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8780088/
- https://pubmed.ncbi.nlm.nih.gov/38667776/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11351696/
- DuteilL, et al. (2016) Specific natural bioactive type 1 collagen peptides oral intake reverse skin aging signs in mature women. J Aging Res Clin Practice 5(2): 84- 92.